Grindlays Pharmaceuticals Pvt Ltd, a active private limited company, was established on 04 September 1985 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U99999MH1985PTC037368. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 12 professional, Its leadership includes Arti Ramkrishna Kolwankar (Director), Ramkrishna Harishet Kolwankar (Managing Director), Santosh Ramkrishna Kolwankar (Director). Past directors included Santosh Ramkrishna Kolwankar. It holds ₹5.86 Cr open charges and ₹9.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai, Maharashtra, 400071.
U99999MH1985PTC037368
037368
04 September 1985
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Grindlays Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arti Ramkrishna Kolwankar | Director | 01 Apr 1997 | Current |
| Ramkrishna Harishet Kolwankar | Managing Director | 15 Oct 1985 | Current |
| Santosh Ramkrishna Kolwankar | Director | 16 Nov 2009 | Current |
| Dhanashri Girish Gudi | Director | 31 Mar 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Grindlays Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 104.13% increase. The company also saw a substantial improvement in profitability, with a 165.52% increase in profit. The company's net worth Soared by an impressive increase of 49.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Grindlays Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹58,550,000.00
₹95,960,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2008 | Bank Of India | ₹5.86 Cr | Open |
| 31 Jul 2013 | Deutsche Bank Ag | ₹3.55 Cr | Satisfied |
| 18 Mar 2009 | Bank Of India | ₹1.20 M | Satisfied |
| 27 Sep 2008 | Bank Of India | ₹3.50 Cr | Satisfied |
| 02 Aug 2004 | Bank Of India | ₹1.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Grindlays Pharmaceuticals has a workforce of 12 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Grindlays Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grindlays Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Grindlays Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Grindlays Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge registered on 18 Mar 2009 via Charge ID 10151901 with Bank Of India was fully satisfied on 14 Dec 2020. was recorded as a recent event.
Progress on A charge registered on 27 Sep 2008 via Charge ID 10129799 with Bank Of India was fully satisfied on 14 Dec 2020. was documented.
Progress on A charge registered on 02 Aug 2004 via Charge ID 90214119 with Bank Of India was fully satisfied on 14 Dec 2020. was documented.
A charge registered on 31 Jul 2013 via Charge ID 10448577 with Deutsche Bank Ag was fully satisfied on 19 Nov 2020. was recorded as a recent event.
The CIN of Grindlays Pharmaceuticals Pvt Ltd is U99999MH1985PTC037368.
Grindlays Pharmaceuticals Pvt Ltd is headquartered at Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai, Maharashtra, 400071.
Grindlays Pharmaceuticals Pvt Ltd was incorporated on 04 September 1985.
The current directors of Grindlays Pharmaceuticals Pvt Ltd are
The primary industry of Grindlays Pharmaceuticals Pvt Ltd is Manufacturing.
Grindlays Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Grindlays Pharmaceuticals Pvt Ltd is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Grindlays Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX